Adalimumab vs Conventional Immunosuppression for Uveitis

Created using ChatSlide

This presentation introduces the ADVISE Trial, focusing on its comparison of inflammation treatments and the role of corticosteroids in managing uveitis. The multicentre, randomised trial employs stratification to evaluate protocols for Adalimumab and conventional immunosuppressive drugs (CIDs). We will discuss primary and secondary outcomes, especially the corticosteroid sparing effect, and how these impact visual acuity, quality of life, and adverse events. Results indicate significant...